Immune-Mediated Therapies for Liver Cancer

被引:23
|
作者
Aravalli, Rajagopal N. [1 ]
Steer, Clifford J. [2 ]
机构
[1] Univ Minnesota, Dept Elect & Comp Engn, 200 Union St SE, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Dept Med & Genet Cell Biol & Dev, 420 Delaware St SE, Minneapolis, MN 55455 USA
来源
GENES | 2017年 / 8卷 / 02期
关键词
adaptive immunity; adoptive cell transfer; cancer vaccines; cholangiocarcinoma; hepatocellular carcinoma; immune checkpoint blockade; immunotherapy; innate immunity; tumor immunology; INDUCED KILLER-CELLS; HUMAN CHOLANGIOCARCINOMA CELLS; TUMOR-ASSOCIATED MACROPHAGES; ANTIGEN-PRESENTING CELLS; HEPATOCELLULAR-CARCINOMA; T-CELL; ANTIPLATELET THERAPY; KUPFFER CELLS; ADOPTIVE IMMUNOTHERAPY; RECURRENCE RATES;
D O I
10.3390/genes8020076
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
In recent years, immunotherapy has gained renewed interest as an alternative therapeutic approach for solid tumors. Its premise is based on harnessing the power of the host immune system to destroy tumor cells. Development of immune-mediated therapies, such as vaccines, adoptive transfer of autologous immune cells, and stimulation of host immunity by targeting tumor-evasive mechanisms have advanced cancer immunotherapy. In addition, studies on innate immunity and mechanisms of immune evasion have enhanced our understanding on the immunology of liver cancer. Preclinical and clinical studies with immune-mediated therapies have shown potential benefits in patients with liver cancer. In this review, we summarize current knowledge and recent developments in tumor immunology by focusing on two main primary liver cancers: hepatocellular carcinoma and cholangiocarcinoma.
引用
收藏
页数:20
相关论文
共 50 条
  • [21] IMMUNE-MEDIATED REGRESSION OF METASTATIC NEUROBLASTOMA IN THE LIVER
    ISHIZU, H
    BOVE, KE
    ZIEGLER, MM
    ARYA, G
    JOURNAL OF PEDIATRIC SURGERY, 1994, 29 (02) : 155 - 160
  • [22] Safety of targeted therapies for treating immune-mediated inflammatory diseases
    Hoisnard, L.
    Zureik, M.
    Weill, A.
    Dray-Spira, R.
    Lebrun-Vignes, B.
    Meyer, A.
    Vegas, L. Pina
    Claudepierre, P.
    Mahevas, M.
    Michel, M.
    Cohen, J. L.
    Maury, S.
    El Karoui, K.
    Wolkenstein, P.
    Roy, L.
    Amiot, A.
    Grimbert, P.
    Sbidian, E.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2024, 38 : 43 - 44
  • [23] Vaccination Guidelines for Patients With Immune-Mediated Disorders on Immunosuppressive Therapies
    Papp, Kim A.
    Haraoui, Boulos
    Kumar, Deerli
    Marshall, John K.
    Bissonnette, Robert
    Bitton, Alain
    Bressler, Brian
    Gooderham, Melinda
    Ho, Vincent
    Jamal, Shahin
    Pope, Janet E.
    Steinhart, A. Hillary
    Vinh, Donald C.
    Wade, John
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2019, 23 (01) : 50 - 74
  • [24] Hurdles to the introduction of new therapies for immune-mediated kidney diseases
    Hans-Joachim Anders
    David R. W. Jayne
    Brad H. Rovin
    Nature Reviews Nephrology, 2016, 12 : 205 - 216
  • [25] Hurdles to the introduction of new therapies for immune-mediated kidney diseases
    Anders, Hans-Joachim
    Jayne, David R. W.
    Rovin, Brad H.
    NATURE REVIEWS NEPHROLOGY, 2016, 12 (04) : 205 - 216
  • [26] Immunosuppressive therapies in the management of acquired immune-mediated marrow failures
    Risitano, Antonio M.
    CURRENT OPINION IN HEMATOLOGY, 2012, 19 (01) : 3 - 13
  • [27] Immune-mediated vincristine-induced neuropathy: Unlocking therapies
    Savelieff, Masha G.
    Feldman, Eva L.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2021, 218 (05):
  • [28] Acute liver failure: mechanisms of immune-mediated liver injury
    Wu, Zeguang
    Han, Meifang
    Chen, Tao
    Yan, Weiming
    Ning, Qin
    LIVER INTERNATIONAL, 2010, 30 (06) : 782 - 794
  • [30] Metformin aggravates immune-mediated liver injury in mice
    Vladislav Volarevic
    Maja Misirkic
    Ljubica Vucicevic
    Verica Paunovic
    Bojana Simovic Markovic
    Maja Stojanovic
    Marija Milovanovic
    Vladimir Jakovljevic
    Dragan Micic
    Nebojsa Arsenijevic
    Vladimir Trajkovic
    Miodrag L. Lukic
    Archives of Toxicology, 2015, 89 : 437 - 450